REPORTS

Let’s Pullulate and Expand Your Business

Bisphosphonate Drugs Market - Global Professional Analysis and Forecast to 2026

Oct 26, 2019  |  203 PAGES  |  REPORT CODE: CMM224895
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Bisphosphonate Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.6% during the forecast period.

This report presents the market size and development trends by detailing the Bisphosphonate Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Bisphosphonate Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Bisphosphonate Drugs industry and will help you to build a panoramic view of the industrial development.

Bisphosphonate Drugs Market, By Type:

  • Alendronate

  • Risedronate

  • Zoledronic acid

  • Others

Bisphosphonate Drugs Market, By Application:

  • Orthopedics

  • Oncology

  • Gynaecology

Some of the leading players are as follows:

  • Indevus Pharmaceuticals Inc.

  • Eli Lilly and Company

  • Pfizer Inc.

  • Cell Genesys Inc.

  • Merck & Co., Inc.

  • Medimmune, LLC

  • Bristol-Myers Squibb Company

  • Abbott Laboratories

  • ALZA Corporation

  • Decartis AG

  • AstraZeneca PLC

  • Sanofi SA

  • GlaxoSmithKline Plc

  • Mylan

  • Paladin Labs Inc.

  • OSI Pharmaceuticals, Inc.

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Bisphosphonate Drugs Market: Technology Type Analysis

  • 4.1 Bisphosphonate Drugs Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Bisphosphonate Drugs Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Alendronate

    • 4.3.2 Risedronate

    • 4.3.3 Zoledronic acid

    • 4.3.4 Others

5 Bisphosphonate Drugs Market: Product Analysis

  • 5.1 Bisphosphonate Drugs Product Market Share Analysis, 2018 & 2026

  • 5.2 Bisphosphonate Drugs Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Bisphosphonate Drugs Market: Application Analysis

  • 6.1 Bisphosphonate Drugs Application Market Share Analysis, 2018 & 2026

  • 6.2 Bisphosphonate Drugs Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Orthopedics

    • 6.3.2 Oncology

    • 6.3.3 Gynaecology

7 Bisphosphonate Drugs Market: Regional Analysis

  • 7.1 Bisphosphonate Drugs Regional Market Share Analysis, 2018 & 2026

  • 7.2 Bisphosphonate Drugs Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Indevus Pharmaceuticals Inc.

    • 9.1.1 Indevus Pharmaceuticals Inc. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Eli Lilly and Company

    • 9.2.1 Eli Lilly and Company Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Pfizer Inc.

    • 9.3.1 Pfizer Inc. Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Cell Genesys Inc.

    • 9.4.1 Cell Genesys Inc. Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Merck & Co., Inc.

    • 9.5.1 Merck & Co., Inc. Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Medimmune, LLC

    • 9.6.1 Medimmune, LLC Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Bristol-Myers Squibb Company

    • 9.7.1 Bristol-Myers Squibb Company Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Abbott Laboratories

    • 9.8.1 Abbott Laboratories Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 ALZA Corporation

    • 9.9.1 ALZA Corporation Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Decartis AG

    • 9.10.1 Decartis AG Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 AstraZeneca PLC

    • 9.11.1 AstraZeneca PLC Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Sanofi SA

    • 9.12.1 Sanofi SA Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 GlaxoSmithKline Plc

    • 9.13.1 GlaxoSmithKline Plc Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Mylan

    • 9.14.1 Mylan Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Paladin Labs Inc.

    • 9.15.1 Paladin Labs Inc. Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 OSI Pharmaceuticals, Inc.

    • 9.16.1 OSI Pharmaceuticals, Inc. Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

 

The List of Tables and Figures (Totals 110 Figures and 135 Tables)

  • Figure Alendronate Bisphosphonate Drugs market, 2015 - 2026 (USD Million)

  • Figure Risedronate Bisphosphonate Drugs market, 2015 - 2026 (USD Million)

  • Figure Zoledronic acid Bisphosphonate Drugs market, 2015 - 2026 (USD Million)

  • Figure Others Bisphosphonate Drugs market, 2015 - 2026 (USD Million)

  • Figure Orthopedics market, 2015 - 2026 (USD Million)

  • Figure Oncology market, 2015 - 2026 (USD Million)

  • Figure Gynaecology market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Bisphosphonate Drugs market, by country, 2015 - 2026 (USD Million)

  • Table North America Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table North America Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table North America Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Canada Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Canada Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Europe Bisphosphonate Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Europe Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Europe Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Europe Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Germany Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Germany Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table France Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table France Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Italy Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Italy Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Spain Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Spain Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Bisphosphonate Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table China Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table China Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Japan Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Japan Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table India Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table India Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Bisphosphonate Drugs market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table MEA Bisphosphonate Drugs market, by country, 2015 - 2026 (USD Million)

  • Table MEA Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table MEA Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table MEA Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Bisphosphonate Drugs market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Bisphosphonate Drugs market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Bisphosphonate Drugs market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Indevus Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cell Genesys Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck & Co., Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Medimmune, LLC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bristol-Myers Squibb Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ALZA Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Decartis AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AstraZeneca PLC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi SA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Plc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mylan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Paladin Labs Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table OSI Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top